KCNN4 and ischemic stroke: This differential K+ channel expression pattern suggests that KV1.3 and KCa3.1 inhibitors could be useful to preferentially target detrimental pro‐inflammatory microglia functions in ischemic stroke and other neurological disorders associated with neuroinflammation such as Alzheimer's and Parkinson's disease.